Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson’s Disease.

Pal GD, Hall D, Ouyang B, Phelps J, Alcalay RN, Nichols W, Clark L, Mejia-Santana H, Blasucci1 L, Goetz CG, Comella C, Colcher A, Gan-Or Z, Rouleau GA and Marder K for the CORE-PD Investigators. Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson’s Disease. Movement Disorders Clinical Practice. 2016. PubMed

Case-control and family based association study of PTPRD in Restless Legs Syndrome.

Gan-Or Z, Zhou S, Johnson A, Montplaisir JY, Allen RP, Earley CJ, Desautels A, Dion PA, Xiong L and Rouleau GA. Case-control and family based association study of PTPRD in Restless Legs Syndrome. Movement Disorders Clinical Practice. 2016. PubMed

Down-regulation of B cell related genes in peripheral blood leukocytes of GBA-associated Parkinson’s disease. 

Kobo H, Bar-Shira A, Dahary D, Gan-Or Z, Goldstein O, Giladi N and Orr-Urtreger A. Down-regulation of B cell related genes in peripheral blood leukocytes of GBA-associated Parkinson’s disease. Molecular Genetics and Metabolism. 2016. PubMed

Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis

Leblond CS, Gan-Or Z, Spiegelman D, Laurent SB, Szuto A, Hodgkinson A, Dionne-Laporte A, Provencher P, de Carvalho M, Orrù S, Brunet D, Bouchard JP, Awadalla P, Dupré N, Dion PA and Rouleau GA. Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiology of aging. 2016. PubMed

The emerging role of SMPD1 mutations in Parkinson’s disease; implications for future studies.

Gan-Or Z, Orr-Urtreger A, Alcalay RN, Bressman S,Giladi N and Rouleau GA. The emerging role of SMPD1 mutations in Parkinson’s disease; implications for future studies. Parkinsonism and Related Disorders. 2015. (letter). PubMed

The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease

Gan-Or Z, Amshalom I, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, and Orr-Urtreger A. The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease. Journal of Neurology. 2015. PubMed

GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder

Gan-Or Z, Mirelman A, Postuma RB, Arnulf I, Bar-Shira A, Dauvilliers Y, Desautels A, Gagnon JF, Leblond CS, Frauscher B, Alcalay RN, Saunders-Pullman R, Bressman SB, Marder K, Monaca C, Hogl B, Orr-Urtreger A, Dion PA, Montplaisir JY, Giladi N and Rouleau GA. GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder. Annals of clinical and translational neurology. 2015. PubMed

Genetic perspective on the role of the Autophagy-Lysosome Pathway in Parkinson disease

Gan-Or Z, Dion PA and Rouleau GA. Genetic perspective on the role of the Autophagy-Lysosome Pathway in Parkinson disease. Autophagy. 2015. (review). PubMed

Glucocerebrosidase activity in Parkinson disease with and without GBA mutations

Alcalay RN, Levy OA, Waters C, Fahn S, Ford B, Kuo SH, Mazzoni P, Marder K, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Wolf P, Oliva P and Zhang XK. Glucocerebrosidase activity in Parkinson disease with and without GBA mutations. Brain. 2015. PubMed

PARK16 haplotypes and the importance of protective genetic factors in Parkinson’s disease

Gan-Or Z. PARK16 haplotypes and the importance of protective genetic factors in Parkinson’s disease. Journal of Human Genetics. 2015. (letter). PubMed